Ernexa Therapeutics Inc. Warrants (ERNAW) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Ernexa Therapeutics Inc. Warrants (ERNAW) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $668,298, listed on NASDAQ, employing roughly 5 people, carrying a beta of 2.51 to the broader market. Operating in the preclinical phase, Ernexa Therapeutics Inc. Led by Sanjeev Luther, public since 2024-07-12.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for ERNAW as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →